For the new study, researchers tracked insurance claims from nearly 127,000 overweight or obese adults who started GLP-1 treatment between 2019 and 2024, looking for people taking drugs like semaglutide (Ozempic/Wegovy), tirzepatide (Zepbound/Mounjaro), or liraglutide (Saxenda/Victoza)
He L, Feng A, Guo H, Huang H, Deng Q, Zhao E, et al
This is where many transformation efforts fall short, assuming a standard approach will work everywhere
You should hear a click, followed by a second click, 10 to 15 seconds later once the injection has finished
[6] Beyond pancreatic effects, semaglutide influences glucose regulation through actions on gastrointestinal and central nervous system pathways